People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Pharma, Biotechnology, Other Health Care, Other, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Intrinsic Therapeutics Inc | — | Pharma | Series C | $219.5M | $594.7M | 2012 |
| Carlsmed, Inc. | — | Biotechnology | Series C | $109.1M | $645.4M | 2020 |
| Shoulder Innovations, Inc. | — | Other Health Care | Series B | $84.7M | $106.8M | 2020 |
| Ceterix Orthopaedics, Inc. | — | Other Health Care | Series B | $54.4M | $510.5M | 2012 |
| Rotation Medical Inc | — | Other Health Care | Series B | $51.1M | $177.2M | 2014 |
| Relign Corp | — | Other | Series B | $30.1M | $499.5M | 2018 |
| Razor Medical Instruments, Inc. | — | Healthtech | Pre-Seed | $1.3M | $7.1M | 2020 |
Kevin Sidow at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin Sidow on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joshua Makower | 2 | 10 |
| Ryan Drant | 1 | 24 |
| Ali Behbahani | 1 | 17 |
| Jonathan Root | 1 | 16 |
| Casey Tansey | 1 | 14 |
| Kirk Nielsen | 1 | 13 |
| John Nehra | 1 | 11 |
| Paul Buckman | 1 | 10 |
| Peter Bisgaard | 1 | 9 |
| Jeani Delagardelle | 1 | 8 |
| Fouad Azzam | 1 | 8 |
| Csaba Truckai | 1 | 7 |
| Robert Ball | 1 | 7 |
| Matthew Ahearn | 1 | 6 |
| Geoff Pardo | 1 | 6 |
| David Clapper | 1 | 6 |
| Rodney Perkins | 1 | 6 |
| Charles Warden | 1 | 5 |
| ALEXANDER ARROW | 1 | 5 |
| David Blue | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.